Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ind-Swift
Chandigarh, Chandigarh, Indiaindswiftltd.com ↗
- Ownership
- Private
- Employees
- ~3000
- Development stage
- Other
01
Overview
Ind-Swift manufactures and markets over 750 pharmaceutical and herbal products across major therapeutic areas, with an active portfolio of finished dosage forms and APIs, and exports to 45 countries. Notable achievements include US/EU patents for extended release clarithromycin.
- Therapeutic areas
- ImmunologyEndocrinologyPsychiatryInfectious DiseasesCardiovascularOncologyNeurology
- Modalities
- Small moleculeHerbal drugFormulation
- Industry
- Biotech
Beyond the preview
Go deeper on Ind-Swift.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ind-Swift.